Search results
Volunteers help sick kids reach the top
China Daily· 7 days agoNine-year-old Lyu Jingwen, who is wheelchair-bound due to spinal muscular atrophy, scaled the peaks of Huangshan Mountain in Anhui province ...
‘It’s not rocket science:’ Local disability advocate takes aim at North Myrtle Beach beach tent ban
WBTW Myrtle Beach via Yahoo News· 3 days agoNORTH MYRTLE BEACH, S.C. (WBTW) — Doctor Jim Berry is a local disability advocate whose two sons...
Fairfax firefighters turned this girl's wheelchair into the Scooby Doo Mystery Machine
WJLA· 5 days agoWhen she was just 8 months old, Katherine was diagnosed with spinal muscular atrophy (SMA), a...
James Middleton Shares Touching Tribute to His Goddaughter on IG
PureWow via Yahoo News· 7 days agoEarlier this week, Middleton shared the emotional message in support of his 6-year-old goddaughter,...
Regenxbio CEO to step down after 15 years
BioPharma Dive via Yahoo Finance· 1 day agoKenneth Mills will become chair of the gene therapy developer's board while Curran Simpson, the current chief operating officer, will take his place as...
Petri Dish: Biogen has an airline partner; Takeda's new head of vaccines - Boston Business Journal
The Business Journals· 7 days agoSummer may have arrived in Massachusetts, but the biotech scene is still bustling. The companies...
Biogen Inc. (NASDAQ:BIIB) Shares Sold by Crossmark Global Holdings Inc.
ETF DAILY NEWS· 5 days agoCrossmark Global Holdings Inc. decreased its position in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) by 19.1% during the 4th quarter, HoldingsChannel reports. The institutional investor ...
Here's Why Biogen Inc. (BIIB) is a Strong Momentum Stock
Zacks via Yahoo Finance· 7 days agoBIIB sits at a Zacks Rank #3 (Hold), holds a Momentum Style Score of B, and has a VGM Score of B...
Memorial music festival supports area first responders
WAOW Wausau· 5 days agoThe Bluegrass at the Lake festival is in full swing, and it's bringing the community together in...
Long Island City biotech raises $25M Series B to develop gene therapies
Crain's New York Business· 6 days agoEnvisagenics’ founding scientific team got its start by developing the drug Spinraza, an RNA therapeutic to treat spinal muscular atrophy
